GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 836 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $764,000 | +14.4% | 17,542 | +14.4% | 0.04% | +27.6% |
Q1 2022 | $667,982 | -7.0% | 15,335 | -5.8% | 0.03% | -3.3% |
Q4 2021 | $718,000 | +30.1% | 16,278 | +8.3% | 0.03% | +15.4% |
Q3 2021 | $552,000 | -3.0% | 15,034 | +6.2% | 0.03% | -7.1% |
Q2 2021 | $569,000 | +8.2% | 14,160 | -3.6% | 0.03% | -6.7% |
Q1 2021 | $526,000 | +14.6% | 14,688 | +17.7% | 0.03% | -9.1% |
Q4 2020 | $459,000 | -11.0% | 12,484 | -9.0% | 0.03% | -28.3% |
Q3 2020 | $516,000 | -10.7% | 13,717 | -3.2% | 0.05% | -20.7% |
Q2 2020 | $578,000 | -2.4% | 14,173 | -9.2% | 0.06% | -27.5% |
Q1 2020 | $592,000 | +8.8% | 15,617 | +35.0% | 0.08% | +17.6% |
Q4 2019 | $544,000 | +48.2% | 11,568 | +34.5% | 0.07% | +17.2% |
Q3 2019 | $367,000 | +58.9% | 8,598 | +48.8% | 0.06% | +48.7% |
Q2 2019 | $231,000 | +2.2% | 5,778 | +7.0% | 0.04% | +14.7% |
Q1 2019 | $226,000 | – | 5,401 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |